Lengthy treatment with low-dose 6-mercaptopurine inhibits resistant triple-negative b

[News]

The cover for issue 7 of Oncotarget features Figure 5, "SUM149-MA cells surviving a 6-MP treatment are sensitive to chemotherapeutic drugs," published in "Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine" by Singh, et al. which reported that the authors have reported that a lengthy treatment with low-dose 6-mercaptopurine, a clinically useful anti-inflammatory drug, inhibits such resistant cells.

More... (https://www.news-medical.net/news/20210519/Lengthy-treatment-with-low-dose-6-mercaptopurine-inhibits-resistant-triple-negative-breast-cancer-cells.aspx)